Jefferies analyst Hisae Kawamoto upgraded Kobayashi Pharmaceutical (KBYPF) to Hold from Underperform with an unchanged price target of 4,900 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback